The chemokine CXCL10/IP-10 has already been associated with PD pathophysiology, since IL-1β-induced CXCL10/IP-10 protein expression was potentiated by coexposure to α-synuclein in human A172 astroglial cells [35]. The gene discussed is SNCA; the disease is Parkinson disease.